During the past decade, National Hospital Organization Tokyo National Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Tokyo National Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Tokyo National Hospital" are "Alzheimer Disease" (1 trials), "Asthma" (1 trials), "Extensive Disease Small Cell Lung Cancer" (1 trials), "Idiopathic Interstitial Pneumonia" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "National Hospital Organization Tokyo National Hospital" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Tokyo National Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab-EU" (1 trials), "Bevacizumab-Pfizer" (1 trials), "Carboplatin" (1 trials), "Paclitaxel" (1 trials) and "bapineuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Tokyo National Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "National Hospital Organization Tokyo National Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in National Hospital Organization Tokyo National Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Tokyo National Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".